Early, Deep, Durable Responses of Ciltacabtagene Autoleucel (cilta-cel) Observed in Phase 1b/2 CARTITUDE-1 Study Show Potential of BCMA CAR-T in Treatment of Heavily Pretreated Patients with Multiple Myeloma

  • Deepu Madduri

Press/Media

Period14 Dec 2020

Media coverage

1

Media coverage

  • TitleEarly, Deep, Durable Responses of Ciltacabtagene Autoleucel (cilta-cel) Observed in Phase 1b/2 CARTITUDE-1 Study Show Potential of BCMA CAR-T in Treatment of Heavily Pretreated Patients with Multiple Myeloma
    Media name/outletIbero News
    Country/TerritorySpain
    Date14/12/20
    URLiberonews.com/not_det.php?lang=en&notid=79593
    PersonsDeepu Madduri
View all 1
View less